Acyl-coenzyme A-binding protein regulates beta-oxidation required for growth and survival of non-small cell lung cancer

Cancer Prevention Research

Volumn 7, Issue 7, 2014, Pages 748-757

  Harris, Fredrick T ^a,b   Rahman, S M Jamshedur ^b   Hassanein, Mohamed ^b   Qian, Jun ^b   Hoeksema, Megan D ^b   Chen, Heidi ^b   Eisenberg, Rosana ^b   Chaurand, Pierre ^d   Caprioli, Richard M ^b   Shiota, Masakazu ^b   Massion, Pierre P ^b,c  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DIAZEPAM BINDING INHIBITOR; ETOMOXIR; SHORT HAIRPIN RNA; ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; PALMITIC ACID;

APOPTOSIS; ARTICLE; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; FATTY ACID OXIDATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LOSS OF FUNCTION MUTATION; LUNG ADENOCARCINOMA; LUNG CANCER CELL LINE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLIC STRESS; MITOCHONDRIAL MEMBRANE POTENTIAL; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; TUMOR INVASION; ADENOCARCINOMA; BRONCHUS; CARCINOMA IN SITU; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; LUNG TUMOR; MASS SPECTROMETRY; METABOLISM; MORTALITY; NON SMALL CELL LUNG CANCER; OXIDATION REDUCTION REACTION; PATHOLOGY; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ACETYL COENZYME A; ADENOCARCINOMA; ADENOSINE TRIPHOSPHATE; APOPTOSIS; BLOTTING, WESTERN; BRONCHI; CARCINOMA IN SITU; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CELLS, CULTURED; DIAZEPAM BINDING INHIBITOR; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MEMBRANE POTENTIAL, MITOCHONDRIAL; OXIDATION-REDUCTION; PALMITIC ACID; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84904364344     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-14-0057     Document Type: Article

References (48)

1. Rahman SM, Gonzalez AL, Li M, Seeley EH, Zimmerman LJ, Zhang XJ, et al. Lung cancer diagnosis from proteomic analysis of preinvasive lesions. Cancer Res 2011;71:3009-17.
2. Rahman SM, Shyr Y, Yildiz PB, Gonzalez AL, Li H, Zhang X, et al. Proteomic patterns of preinvasive bronchial lesions. Am J Respir Crit Care Med 2005;172:1556-62. (Pubitemid 43076545)
3. Rasmussen JT, Borchers T, Knudsen J. Comparison of the binding affinities of acyl-CoA-binding protein and fatty-acid-binding protein for long-chain acyl-CoA esters. Biochem J 1990;265:849-55. (Pubitemid 20053891)
4. Rosendal J, Ertbjerg P, Knudsen J. Characterization of ligand binding to acyl-CoA-binding protein. Biochem J 1993;290:321-6. (Pubitemid 23094922)
5. Guidotti A, Forchetti CM, Corda MG, Konkel D, Bennett CD, Costa E. Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci U S A 1983;80:3531-5. (Pubitemid 13060198)
6. Marquardt H, Todaro GJ, Shoyab M. Complete amino acid sequences of bovine and human endozepines. Homology with rat diazepam binding inhibitor. J Biol Chem 1986;261:9727-31. (Pubitemid 17214100)
7. Guidotti A, Konkel DR, Ebstein B, Corda MG, Wise BC, Krutzsch H, et al. Isolation, characterization, and puri fication to homogeneity of a rat brain protein (GABA-modulin). Proc Natl Acad Sci U S A 1982; 79:6084-8. (Pubitemid 13249984)
8. Shoyab M, Gentry LE, Marquardt H, Todaro GJ. Isolation and characterization of a putative endogenous benzodiazepineoid (endozepine) from bovine and human brain. J Biol Chem 1986; 261:11968-73. (Pubitemid 17202750)
9. Mogensen IB, Schulenberg H, Hansen HO, Spener F, Knudsen J. A novel acyl-CoA-binding protein from bovine liver. Effect on fatty acid synthesis. Biochem J 1987;241:189- 92.
10. Yanagibashi K, Ohno Y, Kawamura M, Hall PF. The regulation of intracellular transport of cholesterol in bovine adrenal cells: purification of a novel protein. Endocrinology 1988;123:2075-82.
11. Besman MJ, Yanagibashi K, Lee TD, Kawamura M, Hall PF, Shively JE. Identification of des-(Gly-Ile)-endozepine as an effector of corticotro-pin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc Natl Acad Sci U S A 1989;86:4897-901. (Pubitemid 19182205)
12. Chen ZW, Agerberth B, Gell K, Andersson M, Mutt V, Ostenson CG, et al. Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release. Eur J Biochem 1988;174:239-45.
13. Hansen HO, Andreasen PH, Mandrup S, Kristiansen K, Knudsen J. Induction of acyl-CoA-binding protein and its mRNA in 3T3-L1 cells by insulin during preadipocyte-to-adipocyte differentiation. Biochem J 1991;277:341-4.
14. Rasmussen JT, Faergeman NJ, Kristiansen K, Knudsen J. Acyl-CoA-binding protein (ACBP) can mediate intermembrane acyl-CoA transport and donate acyl-CoA for beta-oxidation and glycerolipid synthesis. Biochem J 1994;299:165-70. (Pubitemid 24106304)
15. Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 2012;21: 297- 308.
16. Corda MG, Ferrari M, Guidotti A, Konkel D, Costa E. Isolation, purification and partial sequence of a neuropeptide (diazepam-binding inhibitor) precursor of an anxiogenic putative ligand for benzodiazepine recognition site. Neurosci Lett 1984;47:319-24. (Pubitemid 14081906)
17. Liu Y. Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer. Prostate Cancer Prostatic Dis 2006;9:230-4. (Pubitemid 44317255)
18. Cornett DS, Reyzer ML, Chaurand P, Caprioli RM: MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat Methods 2007;4:828-33. (Pubitemid 350055580)
19. Chaurand P, Norris JL, Cornett DS, Mobley JA, Caprioli RM. New developments in pro filing and imaging of proteins from tissue sections by MALDI mass spectrometry. J Proteome Res 2006; 5:2889-900. (Pubitemid 44749207)
20. Stoeckli M, Chaurand P, Hallahan DE, Caprioli RM. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med 2001;7:493-6. (Pubitemid 32298555)
21. Hassanein M, Hoeksema MD, Shiota M, Qian J, Harris BK, Chen H, et al. SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival. Clin Cancer Res 2013;19:560-70.
22. Gyorffy B, Surowiak P, Budczies J, Lanczky A. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS ONE 2013;8: e82241.
23. Wang J, Qian J, Hoeksema MD, Zou Y, Espinosa AV, Rahman SM, et al. Integrative genomics analysis identifies candidate drivers at 3q26-29 amplicon in squamous cell carcinoma of the lung. Clin Cancer Res 2013;19:5580- 90.
24. Ocak S, Chen H, Callison C, Gonzalez AL, Massion PP. Expression of focal adhesion kinase in small-cell lung carcinoma. Cancer 2012; 118:1293-301.
25. Egnatchik RA, Leamy AK, Noguchi Y, Shiota M, Young JD. Palmitateinduced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes. Metabolism 2014; 63:283-95.
26. Knudsen J, Mandrup S, Rasmussen JT, Andreasen PH, Poulsen F, Kristiansen K. The function of acyl-CoA-binding protein (ACBP)/ diazepam binding inhibitor (DBI). Mol Cell Biochem 1993;123: 129- 38.
27. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
28. Selby PL, Sherratt HS. Substituted 2-oxiranecarboxylic acids: a new group of candidate hypoglycaemic drugs. Trends Pharmacol Sci 1989;10:495- 500.
29. Reers M, Smiley ST, Mottola-Hartshorn C, Chen A, Lin M, Chen LB. Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol 1995;260:406-17.
30. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281:1309-12. (Pubitemid 28406816)
31. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007;7:763-77. (Pubitemid 47469806)
32. Smathers RL, Petersen DR. The human fatty acid-binding protein family: evolutionary divergences and functions. Hum Genomics 2011;5:170-91.
33. Chmurzynska A. The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet 2006; 47:39-48. (Pubitemid 43232158)
34. Kawamura T, Kanno R, Fujii H, Suzuki T. Expression of liver-type fatty-acid- binding protein, fatty acid synthase and vascular endothelial growth factor in human lung carcinoma. Pathobiology 2005;72:233-40. (Pubitemid 43004466)
35. Levi L, Lobo G, Doud MK, von Lintig J, Seachrist D, Tochtrop GP, et al. Genetic ablation of the fatty acid-binding protein FABP5 suppresses HER2-induced mammary tumorigenesis. Cancer Res 2013;73: 4770-80.
36. Berger WT, Ralph BP, Kaczocha M, Sun J, Balius TE, Rizzo RC, et al. Targeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-in flammatory and anti-nociceptive drugs. PLoS ONE 2012;7:e50968.
37. Pollard C, Nitz M, Baras A, Williams P, Moskaluk C, Theodorescu D. Genoproteomic mining of urothelial cancer suggests {gamma}-glutamyl hydrolase and diazepam-binding inhibitor as putative urinary markers of outcome after chemotherapy. Am J Pathol 2009;175: 1824-30.
38. Lee BC, Cha K, Avraham S, Avraham HK. Microarray analysis of differentially expressed genes associated with human ovarian cancer. Int J Oncol 2004;24:847-51.
39. Abo-Hashema KA, Cake MH, Lukas MA, Knudsen J. The interaction of acyl-CoA with acyl-CoA binding protein and carnitine palmitoyltransferase I. Int J Biochem Cell Biol 2001;33:807-15. (Pubitemid 32524178)
40. Pike LS, Smift AL, Croteau NJ, Ferrick DA, Wu M. Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta 2011; 1807:726-34.
41. Samudio I, Harmancey R, Fiegl M, Kantarjian H, Konopleva M, Korchin B, et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Invest 2010; 120:142-56.
42. Zaugg K, Yao Y, Reilly PT, Kannan K, Kiarash R, Mason J, et al. Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev 2011;25:1041-51.
43. Kuhajda FP. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res 2006;66:5977-80.
44. Menendez JA, Lupu R. Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells. Arch Immunol Ther Exp 2004;52:414-26. (Pubitemid 40123231)
45. Menendez JA, Lupu R. Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells. Curr Opin Clin Nutr Metab Care 2006;9:346-57. (Pubitemid 44101969)
46. Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 2006;9:358- 65.
47. Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 2000;16:202-8. (Pubitemid 30114274)
48. Agarwal AR, Yin F, Cadenas E. Short-term cigarette smoke exposure leads to metabolic alterations in lung alveolar cells. Am J Respir Cell Mol Biol 2014 Mar 13. [Epub ahead of print].